MarketInOut Stock Screener Log In | Sign Up
 

Qiagen N.V.

NYSE • Healthcare • Diagnostics & Research • Quote as of 05/13/2026 16:00
Qiagen N.V. stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNYSE
Market Capitalization6,808.71 mln
Float205 mln
Earnings Date08/11/2026

EPS

1.96
Moderate

P / E

16.68
Moderately valued

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-2.58
Likely reliable

1-Year Forecast

46.32
Exceptional upside

Relative Strength

19 / 100
Significantly lagging

Business Description

Founded in 1984 and based in Venlo, the Netherlands, Qiagen N.V. is a global company that helps researchers and medical professionals extract meaningful information from biological samples. It supplies a broad range of tools and kits for processing and analyzing genetic material, along with instruments that support testing in areas such as cancer, infectious disease, prenatal health, and forensics. The company also provides software and data analysis services to help customers interpret complex genetic information.

Key Fundamentals

EPS1.96
P/E16.68
ROE11.86
RPS10.05
ROIC9.99
ROA7.11
Interest Cover15.65
EBITDA, mln717
EV / EBITDA11.90
EV / EBIT16.30
Revenue, mln2,090
EV / Revenue4.08

Financial Strength

Altman Z-Score3.39
Piotroski F-Score 8 / 9
Beneish M-Score-2.58
Price to Intrinsic Value1.01
Price to Graham Number2.51
1-Year Target Price46.32
Shiller PE Ratio24.84
Short Ratio3.68
Short % of Float3.19

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -5.05% 14 / 100   
1 Month -21.7% 2 / 100   
2 Months -36.76% 2 / 100   
6 Months -24.25% 8 / 100   
1 Year -23.88% 9 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us